JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 15 No. 12 1153-1157
© 1974 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ackerhalt, R. E.
Right arrow Articles by Sondel, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ackerhalt, R. E.
Right arrow Articles by Sondel, J. A.

A Comparative Study of Three 99mTc-Labeled Phosphorus Compounds and 18F-Fluoride for Skeletal Imaging

R. E. Ackerhalt, M. Blau, S. Bakshi and J. A. Sondel

Roswell Park Memorial Institute and State University of New York at Buffalo Medical School, Buffalo, New York

Correspondence: For reprints contact: R. E. Ackerhalt, Dept. of Nuclear Medicine, School of Medicine, State University of New York, 3435 Main St., Buffalo, N.Y. 14214.

ABSTRACT

The advantages of 99mTc-labeled bone-imaging agents have stimulated a considerable amount of work toward the development of these radiopharmaceuticals. A comparison was made of the biologic properties of 99mTc-Sn-polyphosphate, Sn-pyrophosphate, Sn-1-Hydroxyethane-1-diphosphonate (EHDP), and 18F-fluoride.

Three-hour distribution studies were done in rabbits for each radiopharmaceutical. These radiopharmaceuticals were also administered to patients, and scans were obtained between 3 and 4 hr. These scans were evaluated for background activity due to soft-tissue and blood retention. The blood clearance of 99mTc and 18F was also determined in patients.

On the basis of the above experiments, it was concluded that 99mTc bone-imaging radiopharmaceuticals available to date leave something to be desired in their blood and soft-tissue clearance and high kidney uptake. While the physical properties of 18F are poor, the biologic properties are still superior for bone-imaging. The biologic properties of polyphosphate are significantly worse than pyrophosphate or EHDP. These latter two agents are more similar to 18F in their blood clearance and soft-tissue uptake.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1974 by the Society of Nuclear Medicine.